Planned Curbs on Telehealth Prescriptions Spark Backlash

The proposed plan to tighten limits on prescribing controlled substances through telehealth is facing backlash from medical and patient advocacy groups, creating barriers to care for certain patient populations.

Planned Curbs on Telehealth Prescriptions Spark Backlash
  • Federal plan to tighten limits on prescribing controlled substances through telehealth is facing backlash from medical and patient advocacy groups.
  • Proposed rules would allow remote prescription of a 30-day supply of some drugs, including buprenorphine for opioid-use disorder, but require at least one in-person visit for further prescriptions.
  • Pressure from critics is spurring the Biden administration to expand the amount of time that patients taking buprenorphine have to show up to an in-person appointment.
  • In-person requirement will make it harder for certain patient populations who live in rural areas or face long waits to see a provider.
  • Medical groups say the in-person mandate isn't the solution to possible fraud and the DEA has rushed through the proposal.
Planned Curbs on Telehealth Prescriptions Spark Backlash
Patients taking buprenorphine for opioid-use disorder would be among those most affected